Back to results
US 11,891,446 B2Granted
Highly potent antibodies binding to death receptor 5
AssigneeGalaxy Biotech, LLC
InventorsKyung Jin Kim, Hangil Park, Lihong Wang, Yi Ding, April Zhang, Maximiliano Vasquez
Life of this patent
Estimating the term…
Abstract
The present invention is directed toward monoclonal antibodies that bind to death receptor 4 and/or death receptor 5, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Claims11
A monoclonal antibody (mAb) that binds to a death receptor 5 and which comprises a light chain variable (V) region having three CDRs from the light chain V region sequence of SEQ ID NO:
- 12 and a heavy chain V region having three CDRs from the heavy chain V region sequence of SEQ ID NO:
- 16.
Dependencies are inferred from the claim text.